These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


73 related items for PubMed ID: 20667441

  • 21. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
    Palker T, Kiseleva I, Johnston K, Su Q, Toner T, Szymkowiak C, Kwan WS, Rubin B, Petrukhin L, Wlochowski J, Monteiro J, Kraiouchkine N, DiStefano D, Rudenko L, Shaw A, Youil R.
    Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
    [Abstract] [Full Text] [Related]

  • 22. Quantification of immunoreactive viral influenza proteins by immunoaffinity capture and isotope-dilution liquid chromatography-tandem mass spectrometry.
    Pierce CL, Williams TL, Moura H, Pirkle JL, Cox NJ, Stevens J, Donis RO, Barr JR.
    Anal Chem; 2011 Jun 15; 83(12):4729-37. PubMed ID: 21591780
    [Abstract] [Full Text] [Related]

  • 23. Mass spectrometry analysis of the influenza virus.
    Downard KM, Morrissey B, Schwahn AB.
    Mass Spectrom Rev; 2009 Jun 15; 28(1):35-49. PubMed ID: 18785239
    [Abstract] [Full Text] [Related]

  • 24. Hemagglutinin specificity and neuraminidase coding capacity of neuraminidase-deficient influenza viruses.
    Yang P, Bansal A, Liu C, Air GM.
    Virology; 1997 Mar 03; 229(1):155-65. PubMed ID: 9123857
    [Abstract] [Full Text] [Related]

  • 25. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM.
    Vaccine; 2007 May 10; 25(19):3871-8. PubMed ID: 17337102
    [Abstract] [Full Text] [Related]

  • 26. Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines.
    Getie-Kebtie M, Sultana I, Eichelberger M, Alterman M.
    Influenza Other Respir Viruses; 2013 Jul 10; 7(4):521-30. PubMed ID: 22943763
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.
    Schmeisser F, Vodeiko GM, Lugovtsev VY, Stout RR, Weir JP.
    Vaccine; 2010 Mar 11; 28(12):2442-9. PubMed ID: 20074687
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Identification of seasonal vaccine hemagglutinin subtype 1 (H1) epitopes in Mexican isolates of the new influenza A (H1N1) 2009 virus.
    Rodríguez-Alvarez M, Velasco-Velasco AM, Alvarez-Anell NJ, Jiménez-Corona ME, de León-Rosales SP.
    Arch Med Res; 2009 Nov 11; 40(8):687-92. PubMed ID: 20304258
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.